Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
BridgeBio Pharma, Inc. (BBIO) had Return on Equity of 7.34% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$194.51M |
|
$-164.04M |
|
$9.94M |
|
$184.58M |
|
$300.47M |
|
$-105.96M |
|
$-60.60M |
|
$-166.56M |
|
$-166.56M |
|
$-166.56M |
|
$-166.56M |
|
$-166.56M |
|
$-166.56M |
|
$-105.96M |
|
$-102.95M |
|
194.79M |
|
194.79M |
|
$-0.84 |
|
$-0.84 |
|
| Balance Sheet Financials | |
$1.24B |
|
$4.94M |
|
$129.68M |
|
$1.37B |
|
$816.37M |
|
$1.93B |
|
$2.82B |
|
$3.64B |
|
$-2.27B |
|
$-2.30B |
|
$-2.27B |
|
195.71M |
|
| Cash Flow Statement Financials | |
$-197.28M |
|
$-42.73M |
|
$549.89M |
|
$572.14M |
|
$882.02M |
|
$309.88M |
|
$33.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.52 |
|
-- |
|
-- |
|
-5.63 |
|
-1.09 |
|
94.89% |
|
-54.47% |
|
-54.47% |
|
-- |
|
-85.63% |
|
-84.33% |
|
$-197.35M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.30 |
|
0.95 |
|
94.96 |
|
|
Return on Equity |
7.34% |
7.26% |
|
-12.15% |
|
48.72% |
|
$-11.59 |
|
$-1.01 |
|
$-1.01 |
|